AZD-4818

DB12002InvestigationalSmall molecule

AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).

Mechanism: Pharmacologically active on C-C chemokine receptor type 1
Curator reviewed
Formula / weight: C₂₇H₃₂Cl₂N₂O₇ · 567.46 g/mol (avg)
Code names: AZD4818

Resolves to

Compound

Structure

InChIKeyHVTUHSABWJPWNK-SFHVURJKSA-NSMILESCNC(=O)C1=C(OC[C@@H](O)CN2CCC3(CC4=CC(Cl)=CC=C4O3)CC2)C=C(OC(C)(C)C(O)=O)C(Cl)=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with AZD-4818, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.